Alto Neuroscience ANRO
NYSE ANRO
$21.83 -0.38 (-1.69%)
As of: Oct 23, 2026 · 3:20 PM EDT

Alto Neuroscience (ANRO) Net Preferred Shares Issued and Repurchased (2023)

Updated

Analysis

Alto Neuroscience (ANRO) Net Preferred Shares Issued and Repurchased (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,129.96 Bn 1,098.54 Bn 19.71 Bn -
2 Johnson & Johnson 635.65 Bn 555.51 Bn 17.30 Bn -
3 AbbVie 504.89 Bn 478.00 Bn 12.70 Bn -
4 Merck 358.50 Bn 312.87 Bn 12.21 Bn -
5 Novartis Ag 291.04 Bn 255.03 Bn 11.24 Bn -
6 Astrazeneca 265.27 Bn 238.95 Bn 12.86 Bn -
7 Amgen 237.76 Bn 193.16 Bn 7.24 Bn -
8 Gilead Sciences 195.00 Bn 169.20 Bn 6.22 Bn -
9 Pfizer 171.37 Bn 118.02 Bn 10.94 Bn -
10 Alto Neuroscience 934.39 Mn 112.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 45.00 Mn
Mar 31, 2023 25.00 Mn
API Access

Alto Neuroscience Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=ANRO&period=max&api_key=YOUR_API_KEY